icon-folder.gif   Conference Reports for NATAP  
 
  14th European AIDS Conference
Oct 16-19 2013
Brussels, Belgium
Back grey_arrow_rt.gif
 
 
 
Simeprevir with peginterferon/ribavirin in treatment-na´ve or experienced patients with chronic HCV genotype 4 infection: Interim results of a Phase III trial
 
 
  Reported by Jules Levin, 14th European AIDS Conference (EACS) 16-19 October 2013 · Brussels, Belgium
 
Christophe Moreno,1 Christophe Hezode,2 Patrick Marcellin,3 Stefan Bourgeois,4 Sven Francque,5 Didier Samuel,6 Fabien Zoulim,7 Jean-Didier Grange,8 Wolfgang Jessner,9 Oliver Lenz,9 Monika Peeters,9 Sivi Ouwerkerk-Mahadevan,10 Maria Beumont-Mauviel9
1ULB Hopital Erasme, Brussels, Belgium; 2Hopital Henri Mondor, Creteil, France; 3Hopital Beaujon, Clichy, France; 4ZNA Campus Stuivenberg, Antwerp, Belgium; 5UZ Antwerpen, Antwerp, Belgium; 6Hopital Paul-Brousse, Villejuif, France; 7Hopital de la Croix Rousse, Lyon, France; 8Hopital Tenon, Paris, France; 9Janssen Infectious Diseases BVBA, Beerse, Belgium; 10Janssen Research & Development, Beerse, Belgium

ID1.gif

ID2.gif

ID3.gif

ID4.gif

ID5.gif

ID6.gif

ID7.gif

ID8.gif